CONTINUE TO SITE
OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Validation Changes to the USP Assay Method for Ibuprofen Tablets
March 1, 2002
Ranga Velagaleti, PhD , James Ward , Pam Anderson , Lynn Massad , Philip Burns
Ranga Velagaleti, PhD
Ranga Velagaleti is the manager of laboratory and stability at BASF Corporation, 8800 Line Ave., Shreveport, LA 71106, tel. 318.861.8040, fax 318.861.8004, velagar1@basf-corp.com
James Ward
Pam Anderson
Pam Anderson is a laboratory chemist at BASF Corporation.
Lynn Massad
Lynn Massad is a laboratory chemist at BASF Corporation.
Philip Burns
Philip Burns is the manager of quality control at BASF Corporation.
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2002, Volume 26, Issue 3
This study investigated the effectiveness of the direct extraction of tablets and shaking time on the disintegration of tablets, solubilization, and recovery of ibuprofen from tablets of various formulations, strengths, and spiked placebo.
Related Content: